Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000146142 | SCV000193360 | likely benign | not specified | 2014-01-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000906216 | SCV001050839 | likely benign | not provided | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000906216 | SCV001897031 | benign | not provided | 2019-07-24 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002505127 | SCV002804844 | likely benign | Wiedemann-Steiner syndrome | 2022-01-06 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000906216 | SCV004129396 | likely benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | KMT2A: BP4, BS1 |
Breakthrough Genomics, |
RCV000906216 | SCV005212761 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003935248 | SCV004755843 | likely benign | KMT2A-related disorder | 2019-05-30 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |